1. Home
  2. ESQ vs MLYS Comparison

ESQ vs MLYS Comparison

Compare ESQ & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$107.21

Market Cap

858.2M

Sector

Finance

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$36.99

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESQ
MLYS
Founded
2006
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.2M
3.1B
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
ESQ
MLYS
Price
$107.21
$36.99
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$113.00
$46.40
AVG Volume (30 Days)
72.0K
1.7M
Earning Date
01-22-2026
11-10-2025
Dividend Yield
0.65%
N/A
EPS Growth
14.70
N/A
EPS
5.68
N/A
Revenue
$131,743,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$18.55
N/A
P/E Ratio
$18.88
N/A
Revenue Growth
13.37
N/A
52 Week Low
$68.90
$8.24
52 Week High
$108.55
$47.65

Technical Indicators

Market Signals
Indicator
ESQ
MLYS
Relative Strength Index (RSI) 67.82 40.09
Support Level $100.63 $35.77
Resistance Level $108.55 $44.13
Average True Range (ATR) 2.74 1.93
MACD 0.58 -0.64
Stochastic Oscillator 87.64 14.95

Price Performance

Historical Comparison
ESQ
MLYS

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: